RxDoctor Payments Data

Joana Colzani-Cohen-Deutsch, MD

Family Medicine · Edenton, NCNPI 1972153146

Payments from drug & device makers

$1,955in general payments, 2019–2025

Across 104 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Corcept Therapeutics$493
  • Novo Nordisk$251
  • Pfizer$180
  • Merck$178
  • Phathom Pharmaceuticals, Inc.$155
  • AbbVie$150
  • plus $547 from 15 others

What the payments were for

  • Food & beverage$1,955100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,955 in reported general payments places this provider in the 75th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$112,430
Medicare patients
287
Services billed
2,428

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
KorlymMifepristone14$540,188
JardianceEmpagliflozin73$57,744
MounjaroTirzepatide40$44,470
OzempicSemaglutide36$37,516
EliquisApixaban27$24,010
JanuviaSitagliptin Phosphate20$19,499
Repatha SureclickEvolocumab14$9,601
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,953
SymbicortBudesonide/Formoterol Fumarate17$5,195
DuleraMometasone/Formoterol12$3,799
Solifenacin Succinate20$1,764
Omeprazole100$1,373
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen52$1,129
Fluticasone-SalmeterolFluticasone Propion/Salmeterol13$1,123
Atorvastatin Calcium170$1,074

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Corcept TherapeuticsKorlym$493$540,18814 claims
Boehringer IngelheimJardiance$75$57,74473 claims
Lilly USA, LLCMounjaro$82$44,47040 claims
Novo NordiskOzempic$251$37,51636 claims
PfizerEliquis$180$24,01027 claims
MerckJanuvia, Dulera$178$23,29832 claims
AstraZenecaBreztri Aerosphere, Symbicort$17$13,14829 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Edenton

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →